Status:
COMPLETED
Proteomic Profiles in Trabeculectomy Patients
Lead Sponsor:
Singapore National Eye Centre
Conditions:
Glaucoma
Eligibility:
All Genders
21-99 years
Brief Summary
Approximately 70 million people world-wide are affected with glaucoma, of whom 6.7 million have bilateral blindness.5 Elevated intro-ocular pressure is the major modifiable risk factor in glaucoma, an...
Detailed Description
Study Objectives and Purpose There are two primary aims in this study: 1. To assess changes in the tear proteomic profiles in pre-trabeculectomy and post-trabeculectomy patients 2. To assess the cha...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 120 patients will be recruited from glaucoma clinics in SNEC
- Patients age ≥ 21 years old
- Patients who require trabeculectomy operation
Exclusion
Key Trial Info
Start Date :
November 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01841580
Start Date
November 1 2013
End Date
October 1 2018
Last Update
October 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore National Eye Centre/ Singapore Eye Research Institute
Singapore, Singapore, 168751